Business News

The-Newyork-Times-NYT-072914-lg.jpgDiversified media company New York Times Co. reported Tuesday a profit for the second quarter that more than halved from last year, as an increase in circulation revenues failed to offset slumping ad sales. Both adjusted earnings per share from continuing operations and quarterly revenues came in below analysts' expectations.

FDA Performs Inspection Of Impax Labs.'s Taiwan Facility - Quick Facts

The U.S. Food and Drug Administration or FDA performed a general GMP inspection and a Pre-Approval Inspection for RYTARYTM at Impax Laboratories, Inc.'s (IPXL) Taiwan manufacturing facility from July 21 to July 26, 2014. As a result of the inspection, the FDA issued a Form 483 with 10 inspectional observations....

Latest News

Express Scripts Q2 Profit Tops Estimate

Express Scripts Holding Company (ESRX) reported net income for the second quarter of $515.2 million or $0.67 per share, compared to $543.0 million or $0.66 per share for the year-ago quarter. Excluding items, adjusted net income for the latest quarter was $939.4 million or $1.23 per share. Revenue...

U.S. Consumer Confidence Jumps To Nearly Seven-Year High In July

Consumer confidence in the U.S. improved for the third consecutive month in July, according to a report released by the Conference Board on Tuesday, with the consumer confidence index jumping to its highest level in almost seven years.

U.S. Consumer Confidence Index Jumps To 90.9 In July


Charlesbank Capital Partners Portfolio Company Princeton Review Agrees To Be Acquired By IAC'

TreeHouse Foods Completes Acquisition Of Flagstone Foods

Expedia Completes Acquisition Of Auto Escape Group

AmREIT Explores Strategic Alternatives; Rejects Regency Centers’ $22/Shr Proposal


Buffalo Wild Wings (BWLD) Is Sinking After Q2 Report

Buffalo Wild Wings (BWLD) reported second quarter EPS of $1.25 after the bell Tuesday, compared to $0.88 a year ago. The consensus estimate was for EPS of $1.20. Total revenue increased 20.0% to $366.0 million. Analysts were expecting EPS of $359.5 million. The company also stated that full year 2014...

ContraFect Prices IPO At $6.00 Per Unit

ContraFect Corp. (CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, announced the pricing of its initial public offering of 6 million units priced at $6.00 per unit for total gross proceeds of $36 million. The offering was priced...

CBRE Group Q2 14 Earnings Conference Call At 5:00 PM ET

CBRE Group Inc. (CBG) will host a conference call at 5:00 PM ET July 29, 2014, to discuss its Q2 14 earnings results. To access the live webcast, log on at A call can be accessed by dialing 877.407.8037 (US) or 201.689.8037 (International) For replay a call, dial 877.660.6853...